Brought to you by 
Xtent nets $67.8mm with IPO
Aug 2006
Executive Summary
Xtent (drug-eluting systems for coronary artery disease) has netted $67.8mm
through the initial public offering of 4.7mm common shares priced at $16 each, the low end of its anticipated $16-18 range.
Deal Industry
-
Medical Devices
- Implantable Devices
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Xtent nets $67.8mm with IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice